MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Analyzing Longitudinal Correlation Between CSF Tau, Alpha-Synuclein, and Dysautonomia in Parkinson’s Disease Over Five Years

    C. Song, J. Ruiz Tejeda, R. Rajmohan, N. Phielipp (Irvine, USA)

    Objective: To examine the longitudinal association between tau, alpha-synuclein, and dysautonomia in Parkinson’s disease (PD). Background: PD is characterized by dopaminergic neural loss [1] and…
  • 2025 International Congress

    Amplification Parameters of the Alpha-Synuclein Seed Amplification Assay on CSF Predict the Clinical Subtype of Parkinson’s Disease at 10-Year Follow-Up

    P. Grillo, GM. Riboldi, A. Pisani, UJ. Kang, SM. Fereshtehnejad (Pavia, Italy)

    Objective: To assess the association between the parameters of alpha-synuclein seed amplification assay on CSF (CSF-αSyn-SAA) within 2 years from Parkinson’s disease (PD) onset and…
  • 2025 International Congress

    Advancing the regulatory maturity of digital health technologies with focus on early intervention, Critical Path for Parkinson’s 3DT initiative

    D. Stephenson, C. Coon, J. Cosman, M. Dockendorf, S. Dolan, J. Edgerton, L. Gaetano, E. Goikoetxea, D. Hill, G. Jones, S. Jorgensen, T. Kangarloo, C. Kopil, G. Lee, J. Mammen, A. Mirelman, C. Ollivier, K. Romero, S. Sardar, Y. Xiao, M. Müller, J. Adams (Tucson, USA)

    Objective: To report the feedback from global regulatory agencies to Critical Path Institute (C-Path) on the use of digital health technologies (DHTs) for Parkinson’s disease…
  • 2025 International Congress

    Predictors of suicidal ideation amongst people with parkinsonism in the PRIME-UK cross-sectional study

    S. Haworth, A. Nodehi, Y. Ben-Shlomo, E. Henderson, E. Tenison (Bristol, United Kingdom)

    Objective: To assess the frequency of, and predictors of, suicidal ideation (SI) in people with parkinsonism (PwP). Background: Both the neuropsychiatric and motor features, coupled…
  • 2025 International Congress

    Cognitive Assessment in Parkinson’s Disease: A Mixed Methods Study of Current Neuropsychology Practices in Australia

    J. King, D. Pourzinal, J. Yang, D. Brooks, D. Sriram, K. Sivakumaran, L. Mitchell, N. Dissanayaka (HERSTON, Australia)

    Objective: To investigate the role of neuropsychologists, and their current practices for assessing cognition in Parkinson’s disease (PD). Background: Diagnosis and evaluation of cognitive disorders…
  • 2025 International Congress

    Negative Correlation Between Apathy and Performance on Memory Tasks in Patients with Idiopathic Parkinson’s Disease without Dementia.

    J. Felipe Ayala-Rico, C. Alberto Hurtado-González, S. Ospinta-Otalvaro, P. Andrea Gutiérrez-Lenis, A. Lucumi-Moreno, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, K. Valbuena-Epiayu (Cali, Colombia)

    Objective: To establish the impact of apathy on memory functioning in patients with IPDWD. Background: Memory is one of the domains of neurocognitive functioning that…
  • 2025 International Congress

    Poor sleep quality is one of the causes of cognitive decline in Parkinson’s disease (PD)-1

    K. Hasegawa, M. Miyashita, M. Sagawa, A. Kawanami (Kanagawa, Japan)

    Objective: The purpose of this study was to clarify the relationship between sleep disorders and cognitive function in PD by overnight electroencephalogram (EEG) and sleep…
  • 2025 International Congress

    Exploring Visual Scanning Behavior and Novelty Seeking in Parkinson’s Disease: A Pilot Study

    K. Paulk, H. Ferguson, L. Neilson, N. Hantke (New Orleans, USA)

    Objective: To assess the feasibility of eye-tracking metrics in a Visual Paired Comparison (VPC) task as biomarkers for impulsivity in Parkinson's disease (PD) and to…
  • 2025 International Congress

    Correlational Analysis between Anxiety and Self-perception of Health in Patients with and without Idiopathic Parkinson’s Disease without Dementia.

    S. Ospina Otalvaro, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, P. Andrea Gutiérrez-Leni, A. Lucumi-Moreno, S. Cárdenas-Zuñiga, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, E. Muñoz-Alvarez (Cali, Colombia)

    Objective: To analyze the impact of anxiety on self-perception of health in patients with Idiopathic Parkinson's Disease Without Dementia. Background: After depression in Idiopathic Parkinson's…
  • 2025 International Congress

    Effects of transmembrane protein 106B genetic variations on disease progression in Parkinson’s disease

    Y. Fan, W. Zhao, X. Liang, Y. Sun, J. Wang (Shanghai, China)

    Objective: This study aimed to explore whether the variants of Transmembrane protein 106B (TMEM106B) influence clinical phenotypes’ trajectory in Parkinson’s disease (PD). Background: TMEM106B variations are…
  • « Previous Page
  • 1
  • …
  • 119
  • 120
  • 121
  • 122
  • 123
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley